Cannabinoids: New Research on Pain Management
A recent study published in the Journal of Cannabis Research highlights the potential of cannabinoids, specifically THC (tetrahydrocannabinol), CBD (cannabidiol), and terpenes, in reducing the reliance on opioids for pain management. Conducted by researchers from the Hadassah Hebrew University Medical Center in Jerusalem, the study involved 69 patients suffering from acute radicular pain—a severe condition often resulting from nerve root compression or irritation. The results show a remarkable nearly 50% reduction in morphine consumption among patients who received cannabinoid preparations.
How Were Patients Treated in This Clinical Trial?
The randomized clinical trial included 69 adult participants with confirmed severe radicular pain, verified through CT or MRI scans. They were assigned to one of three groups: a high-dose cannabinoid preparation, a low-dose preparation, or a placebo. The high-dose group received 19.8 mg of THC and 19.8 mg of CBD, while the low-dose group received 9.9 mg of each, both combined with beneficial terpenes. These preparations were administered sublingually for effective absorption.
What Were the Findings on Morphine Use?
Within just 24 hours of administration, those in the high-dose cannabinoid group consumed an average of 17.4 mg of intravenous morphine, compared to 33.2 mg in the placebo group. This represents a significant 47.6% reduction in morphine usage without increasing pain intensity. In fact, patients receiving the cannabinoid preparation reported pain levels similar to those of the placebo group, indicating that cannabinoids can effectively help manage pain while reducing opioid dependency.
Were There Any Side Effects?
Adverse effects were monitored in the study, with only three participants experiencing transient hallucinations—one in the high-dose group and two in the low-dose group. Notably, these episodes resolved within an hour without any medical intervention, and no participants withdrew from the study due to adverse events. This suggests that the cannabinoid preparations were well-tolerated.
What Do These Findings Mean for Pain Management?
The authors of the study concluded that cannabinoid preparations demonstrated an opioid-sparing effect, making them a promising adjunct to traditional analgesics in acute care settings. As the medical community continues to address the opioid crisis, these findings highlight the potential role of cannabis-based therapies in managing pain safely and effectively.
With the growing interest in cannabis as a therapeutic option, this study opens up new avenues for pain management, especially for patients in acute situations. By integrating THC, CBD, and terpenes into treatment plans, healthcare professionals could potentially reduce opioid prescriptions and improve patient outcomes. As research progresses, the hope is that cannabinoid-based therapies will become a standard companion in pain management strategies.
More From Soft Secrets:
Cannabis Terpenes May Relieve Pain Without Causing a High, Study Finds
The Efficacy of Cannabis in Alleviating Chronic Pain
L
Liz Filmer
